Used for treatment of HER2-positive metastatic and early breast cancers ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the ...

Aurobindo Pharma Ltd ( ($IN:AUROPHARMA) ) just unveiled an update. CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, has received a positive ...

Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...

The shares of the Mid-Cap company specializing in the development, manufacturing, and commercialization of generic ...

The up move in the stock came after the company arm Eugia Pharma Specialities, received final approval from USFDA to ...

Aurobindo Pharma's shares rose nearly 3% after its subsidiary, Eugia Pharma, received USFDA approval to market Dasatinib ...

Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib ...

After a consistent five-day rally, the market may consolidate, though the overall trend remains positive. Below are some ...

India supplies over 45% of the generics and 15% of biosimilars used in the U.S., with major companies like Dr. Reddy’s, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma earning ...

The court ruled in favour of Astellas Pharma regarding the validity of its US patent (the ’780 patent) and noted that issues ...

The European active pharmaceutical ingredients (API) market has exhibited robust growth in recent years, underscored by a valuation of $49.52 billion in 2021. This report delves into the factors ...